Healio

FDA approves Linzess as first treatment for pediatric functional constipation

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Linzess, the first therapy for pediatric functional constipation in patients aged 6 to 17 ...
Healio

FDA grants priority review to Linzess for functional constipation in children, teens

Please provide your email address to receive an email when new articles are posted on . The FDA has granted priority review to a supplemental new drug application for Linzess for the treatment of ...
Becker's ASC

FDA Approves Linzess for Irritable Bowel Syndrome and Constipation

FDA has announced it has approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation in adults, according to a news release. Linzess ...
Seeking Alpha

FDA approves Ironwood's constipation drug Linzess for pediatric use

The US Food and Drug Administration has expanded its approval of Ironwood Pharmaceuticals' (NASDAQ:IRWD) drug Linzess to include the treatment of functional constipation in children and teens. Linzess ...
Business Wire

Ironwood to Present New Data at NASPGHAN Annual Meeting Reinforcing Impact of Linaclotide on Functional Constipation in Children and Adolescents Ages 6-17 Years-Old

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a leading global gastrointestinal healthcare company, will present findings during the 2023 North American Society for Pediatric ...
Staten Island Advance

Dear Doctor: Not all treatments for constipation are pricy

What can you tell me about a prescription of 145 mcg of Linzess, and why a doctor would prescribe a pill over $500? What are the advantages to taking this? Surely, there must be something less ...
Business Wire

Ironwood Pharmaceuticals Announces FDA Approval of Revised LINZESS ® (linaclotide) Label

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for ...
Nasdaq

Ironwood (IRWD) Gets FDA Priority Tag for Linzess sNDA

Ironwood Pharmaceuticals IRWD announced that the FDA has accepted and granted priority review to a supplemental new drug application (sNDA), seeking expanded use of Linzess (linaclotide) for children ...
Sun Journal

Prescription for constipation costs $500 for a month’s supply

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: What can you tell me about a prescription of 145 mcg of ...